464Wire StoriesKDDI Uses Wind River Studio for Its Commercial Deployment of 5G Open vRAN Sites in Japan
ALAMEDA, Calif.–(BUSINESS WIRE)–#5g—Wind River®, a global leader in delivering software for mission-critical intelligent systems, today announced that Wind River Studio is being...
- 444Wire Stories
KDDI Uses Wind River Studio for Its Commercial Deployment of 5G Open vRAN Sites in Japan
ALAMEDA, Calif.–(BUSINESS WIRE)–#5g—Wind River®, a global leader in delivering software for mission-critical intelligent systems, today announced that Wind River Studio is being...
- 446News
Melco garners 97 Stars in 2023 Forbes Travel Guide – maintaining lead among Macau and Asia’s integrated resorts
MACAU – Media OutReach – 15 February 2023 – Melco Resorts & Entertainment has been awarded a collective total of 97 Stars...
- 428Wire Stories
NaturalShrimp Collaborates with Australian Companies in a Prawn Farm Wastewater Trial
DALLAS–(BUSINESS WIRE)–NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture...
- 408Wire Stories
NaturalShrimp Collaborates with Australian Companies in a Prawn Farm Wastewater Trial
DALLAS–(BUSINESS WIRE)–NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture...
- 490Wire Stories
NaturalShrimp Collaborates with Australian Companies in a Prawn Farm Wastewater Trial
DALLAS–(BUSINESS WIRE)–NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture...
- 683Wire Stories
TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)
Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical Group’s NeuPex System at Xiamen Humanity Hospital...
- 415Wire Stories
TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)
Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical Group’s NeuPex System at Xiamen Humanity Hospital...
- 664Wire Stories
TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)
Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical Group’s NeuPex System at Xiamen Humanity Hospital...
- 427Wire Stories
Anteris Announces Completion of A$35 Million Capital Raise and Provides 2023 Goalposts
Company Funded Through Results of U.S. Early Feasibility Study of DurAVR™ BRISBANE, Australia and EAGAN, Minn.–(BUSINESS WIRE)–Anteris Technologies Ltd (ASX: AVR), a...
